Cargando…
TAK1 mRNA Expression in the Tumor Tissue of Locally Advanced Head and Neck Cancer Patients
Resistance to radio and chemotherapy is one of the major drawbacks in the progression of head and neck squamous cell cancer (HNSCC) patients, evidencing the importance of finding optimum molecular prognosis markers to develop personalized treatment schedules. TGF-β effector TAK1 activity has been re...
Autores principales: | Honorato, Beatriz, Alcalde, Juan, Martinez-Monge, Rafael, Zabalegui, Natalia, Garcia-Foncillas, Jesús |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2733096/ https://www.ncbi.nlm.nih.gov/pubmed/19787075 |
Ejemplares similares
-
Review: Mitochondrial Defects in Breast Cancer
por: Salgado, Josefa, et al.
Publicado: (2008) -
Translation control of TAK1 mRNA by hnRNP K modulates LPS-induced macrophage activation
por: Liepelt, Anke, et al.
Publicado: (2014) -
LOCAL ANALGESIA, HEAD AND NECK
Publicado: (1956) -
Quality-of-Life Evaluation of Patients with Unresectable Locally Advanced or Locally Recurrent Head and Neck Carcinoma Treated with Head and Neck Photoimmunotherapy
por: Okamoto, Isaku, et al.
Publicado: (2022) -
A six-mRNA signature model for the prognosis of head and neck squamous cell carcinoma
por: Guo, Wenna, et al.
Publicado: (2017)